Diagnosis and management of common acquired bleeding disorders

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Acquired bleeding disorders (ABD) are commonly encountered in both inpatient and outpatient settings. ABD can occur due to consumption, decreased synthesis, or inhibition of coagulation factors and platelets. Clinical presentation may vary, ranging from mild bruising to life-threatening hemorrhage. The location, frequency, severity, and provocation of bleeding provide insight into the cause of ABD. Obtaining a good medical, surgical, family, social, and medication history is a crucial step in determining the underlying etiology. Basic laboratory parameters, such as prothrombin time, partial thromboplastin time, thrombin time, fibrinogen, platelet count, and D-dimer levels, aid in further elucidating the reason for bleeding. Optimal management depends on accurate interpretation of the history and laboratory values. Treatment options include administration of vitamin K; blood component transfusion, consisting of plasma, cryoprecipitate, and/or platelets; and blood derivatives, including single and multiple factor concentrates. These products should be used judiciously, due to potential infectious and noninfectious complications, including transfusion-related acute lung injury and transfusion-associated circulatory overload. This article discusses the management of the more common causes of ABD.

Original languageEnglish (US)
Pages (from-to)172-181
Number of pages10
JournalSeminars in Thrombosis and Hemostasis
Volume39
Issue number2
DOIs
StatePublished - 2013

Fingerprint

Hemorrhage
Blood Platelets
Blood Component Transfusion
Thrombin Time
Blood Coagulation Factors
Partial Thromboplastin Time
Vitamin K
Acute Lung Injury
Prothrombin Time
Platelet Count
Fibrinogen
Inpatients
Outpatients
History
Therapeutics

Keywords

  • acquired coagulopathy
  • disseminated intravascular coagulation
  • liver disease
  • new oral anticoagulants
  • warfarin reversal

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Diagnosis and management of common acquired bleeding disorders. / De Simone, Nicole; Sarode, Ravi.

In: Seminars in Thrombosis and Hemostasis, Vol. 39, No. 2, 2013, p. 172-181.

Research output: Contribution to journalArticle

@article{51eabd62bd134a4f8418619c2be42e34,
title = "Diagnosis and management of common acquired bleeding disorders",
abstract = "Acquired bleeding disorders (ABD) are commonly encountered in both inpatient and outpatient settings. ABD can occur due to consumption, decreased synthesis, or inhibition of coagulation factors and platelets. Clinical presentation may vary, ranging from mild bruising to life-threatening hemorrhage. The location, frequency, severity, and provocation of bleeding provide insight into the cause of ABD. Obtaining a good medical, surgical, family, social, and medication history is a crucial step in determining the underlying etiology. Basic laboratory parameters, such as prothrombin time, partial thromboplastin time, thrombin time, fibrinogen, platelet count, and D-dimer levels, aid in further elucidating the reason for bleeding. Optimal management depends on accurate interpretation of the history and laboratory values. Treatment options include administration of vitamin K; blood component transfusion, consisting of plasma, cryoprecipitate, and/or platelets; and blood derivatives, including single and multiple factor concentrates. These products should be used judiciously, due to potential infectious and noninfectious complications, including transfusion-related acute lung injury and transfusion-associated circulatory overload. This article discusses the management of the more common causes of ABD.",
keywords = "acquired coagulopathy, disseminated intravascular coagulation, liver disease, new oral anticoagulants, warfarin reversal",
author = "{De Simone}, Nicole and Ravi Sarode",
year = "2013",
doi = "10.1055/s-0032-1333539",
language = "English (US)",
volume = "39",
pages = "172--181",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Diagnosis and management of common acquired bleeding disorders

AU - De Simone, Nicole

AU - Sarode, Ravi

PY - 2013

Y1 - 2013

N2 - Acquired bleeding disorders (ABD) are commonly encountered in both inpatient and outpatient settings. ABD can occur due to consumption, decreased synthesis, or inhibition of coagulation factors and platelets. Clinical presentation may vary, ranging from mild bruising to life-threatening hemorrhage. The location, frequency, severity, and provocation of bleeding provide insight into the cause of ABD. Obtaining a good medical, surgical, family, social, and medication history is a crucial step in determining the underlying etiology. Basic laboratory parameters, such as prothrombin time, partial thromboplastin time, thrombin time, fibrinogen, platelet count, and D-dimer levels, aid in further elucidating the reason for bleeding. Optimal management depends on accurate interpretation of the history and laboratory values. Treatment options include administration of vitamin K; blood component transfusion, consisting of plasma, cryoprecipitate, and/or platelets; and blood derivatives, including single and multiple factor concentrates. These products should be used judiciously, due to potential infectious and noninfectious complications, including transfusion-related acute lung injury and transfusion-associated circulatory overload. This article discusses the management of the more common causes of ABD.

AB - Acquired bleeding disorders (ABD) are commonly encountered in both inpatient and outpatient settings. ABD can occur due to consumption, decreased synthesis, or inhibition of coagulation factors and platelets. Clinical presentation may vary, ranging from mild bruising to life-threatening hemorrhage. The location, frequency, severity, and provocation of bleeding provide insight into the cause of ABD. Obtaining a good medical, surgical, family, social, and medication history is a crucial step in determining the underlying etiology. Basic laboratory parameters, such as prothrombin time, partial thromboplastin time, thrombin time, fibrinogen, platelet count, and D-dimer levels, aid in further elucidating the reason for bleeding. Optimal management depends on accurate interpretation of the history and laboratory values. Treatment options include administration of vitamin K; blood component transfusion, consisting of plasma, cryoprecipitate, and/or platelets; and blood derivatives, including single and multiple factor concentrates. These products should be used judiciously, due to potential infectious and noninfectious complications, including transfusion-related acute lung injury and transfusion-associated circulatory overload. This article discusses the management of the more common causes of ABD.

KW - acquired coagulopathy

KW - disseminated intravascular coagulation

KW - liver disease

KW - new oral anticoagulants

KW - warfarin reversal

UR - http://www.scopus.com/inward/record.url?scp=84874191003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874191003&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1333539

DO - 10.1055/s-0032-1333539

M3 - Article

C2 - 23390026

AN - SCOPUS:84874191003

VL - 39

SP - 172

EP - 181

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 2

ER -